FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

8941001000001100: Not available (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40299001000001111 Not available (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40299101000001112 Not available en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Not available Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely razoxane 125 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely molgramostim 150 microgram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely molgramostim 400 microgram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely amifostine 500 milligram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely amifostine 375 milligram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Interferon alfa-2b 1million iu powder and solvent for injection solution vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely fosfestrol tetrasodium 120 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Fosfestrol tetrasodium 60mg/mL injection solution 5mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely medroxyprogesterone acetate 250 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely medroxyprogesterone acetate 500 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely aminoglutethimide 250 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Ferrous sulfate 160mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Ferric ammonium citrate+folic acid 80mg/500micrograms/5mL syrup VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Ferrous sulfate+folic acid 160mg/400micrograms m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Ferric ammonium citrate+folic acid 80mg/2.5mg/5mL syrup VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Iron sorbitol (50mg/mL Ferrous iron) injection solution 2mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely folic acid 100 microgram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 2.5 gram/1 sachet granules for conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely durapatite 3.32 gram/1 sachet conventional release oral granules (clinical drug) VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely calcium phosphate 3.3 gram/1 sachet powder for conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 420 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely sevelamer 400 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Calcitriol 2micrograms/mL injection solution 1mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely alpha tocopherol acetate 50 international unit/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing alpha tocopheryl acetate 200 mg/1 each oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Phytomenadione 2mg/mL injection solution 0.5mL ampule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely benorilate 750 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Benorylate 2g/5mL s/f suspension VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely azapropazone 600 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely diflunisal 250 milligram/1 each conventional release oral tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely etodolac 200 milligram/1 each conventional release oral capsule VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely flurbiprofen 100 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely ibuprofen 800 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Ibuprofen+codeine phosphate 300mg/20mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Indomethacin 75mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Indomethacin 50mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Indomethacin 25mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Indomethacin 25mg m/r capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Naproxen 500mg m/r tablet VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely naproxen 500 milligram/1 each conventional release rectal suppository VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely piroxicam 20 milligram/1 each conventional release rectal suppository VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Tiaprofenic acid 300mg m/r capsule VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely tiaprofenic acid 200 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Tenoxicam 20mg powder and solvent for injection solution vial VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Sodium hyaluronate 10mg/mL injection solution 2.5ml prefilled syringe VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely rofecoxib 12.5 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely rofecoxib 25 milligram/1 each conventional release oral tablet VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely rofecoxib 2.5 milligram/1 milliliter conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely rofecoxib 5 milligram/1 milliliter conventional release oral suspension VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Turpentine liniment BP VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 milliliter conventional release eye drops VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Neomycin sulfate 0.5% single-use eye drops VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely neomycin sulfate 5 milligram/1 gram conventional release eye ointment VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely epinephrine 10 milligram/1 milliliter conventional release eye drops VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely carbachol 30 milligram/1 milliliter conventional release eye drops VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Pilocarpine nitrate 1% single-use eye drops VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Hypromellose+phenylephrine 0.5/0.12% eye drops VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely polyvinyl alcohol 10 milligram/1 milliliter conventional release eye drops VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Carbenoxolone sodium 1% mouthwash granules VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Nystatin 100,000units pastille VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely benzocaine 20 milligram/1 gram and chloroxylenol 1.06 milligram/1 gram conventional release oromucosal gel VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely domiphen bromide 500 microgram and lidocaine hydrochloride 5 milligram/1 each conventional release oromucosal lozenge VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Povidone-iodine mouthwash+gargle VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Buffered cream BP VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Cetomacrogol Formula B cream BP VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Simple ointment BP VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Chamomile extracts 10.5% ointment VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Calamine oily lotion VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely benzocaine 10 milligram/1 gram and triclosan 2 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram and oxytetracycline (as oxytetracycline hydrochloride) 30 milligram/1 gram conventional release cutaneous ointment VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous cream VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Desoxymethasone 0.05% oily cream VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely halcinonide 1 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous lotion VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Ichthammol 10% ointment BP VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Zinc+ichthammol cream BP VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 500 microgram/1 gram conventional release cutaneous cream VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous lotion VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Erythromycin 3% in benzoyl peroxide topical gel VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous lotion VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Podophyllin compound 15% paint BP VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Neomycin 0.5% cream BPC VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely benzoic acid 60 milligram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier
Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator True Not available Inferred relationship Existential restriction modifier
Product containing precisely metronidazole 10 milligram/1 gram conventional release cutaneous cream VMP non-availability indicator False Not available Inferred relationship Existential restriction modifier

Start Previous Page 74 of 304 Next End

This concept is not in any reference sets

Back to Start